united press international
tuesday, december 21, 2004
rockville, md., dec 20, 2004 (united press international via comtex) —— the u.s. food and drug administration monday said it approved pegaptanib sodium injection, a therapy to slow vision loss caused by macular degeneration.
pegaptanib sodium injection, or macugen, slows vision loss in people with the eye disease neovascular (wet) age-related macular degeneration, known as amd.
"macugen is among the first treatments to target the underlying biology of wet age-related macular degeneration," said dr. lester m. crawford, acting fda commissioner. "macugen provides a needed addition to the treatment of patients with this disease."
amd, a retinal disease causing severe and irreversible vision loss, is a major cause of blindness in individuals older than 55 years. untreated, the majority of eyes affected with wet amd may become functionally blind.
wet amd, which makes up approximately 10 percent of amd, is caused by growth of abnormal leaky blood vessels that eventually damage the area of the eye responsible for central vision, which is essential for most fine detail visual activities, including reading, driving and recognizing faces.
医学英语补充阅读:FDA OKs therapy for macular degeneration.doc正在阅读:
医学英语补充阅读:FDAOKstherapyformaculardegeneration05-02
2019年云南普洱中考化学真题03-30
2020下半年四川中小学教师资格证报名入口:http://ntce.neea.edu.cn11-19
2016年GRE数学歧义如何面对?04-12
2016年政法干警申论范文:美育改革有利于提高综合素质04-12
2019考研政治中公考研_2019考研政治考研大纲03-30
新疆2018年注册会计师考试时间:10月13-14日(专业阶段)03-20
陕西中医学院2018年专升本护理学分数线-陕西中医学院2018年6月英语六级报名入口:http://www.sntcm.edu.cn/04-27
2019年12月安徽英语六级合格分数线公布【附CET6成绩查询入口】01-19
2016山东省枣庄市中考英语真题及答案(Word版)07-15
2018成考各科目考试题型及分值分布情况03-24